Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-033098
Filing Date
2024-08-19
Accepted
2024-08-19 16:44:42
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1311791
2 ex31-1.htm EX-31.1 12413
3 ex31-2.htm EX-31.2 13061
4 ex32-1.htm EX-32.1 8430
  Complete submission text file 0001493152-24-033098.txt   5085341

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tsoi-20240630.xsd EX-101.SCH 32190
6 XBRL CALCULATION FILE tsoi-20240630_cal.xml EX-101.CAL 56143
7 XBRL DEFINITION FILE tsoi-20240630_def.xml EX-101.DEF 142965
8 XBRL LABEL FILE tsoi-20240630_lab.xml EX-101.LAB 279846
9 XBRL PRESENTATION FILE tsoi-20240630_pre.xml EX-101.PRE 231326
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 645589
Mailing Address 701 WILD ROSE LANE ELK CITY ID 83525
Business Address 701 WILD ROSE LANE ELK CITY ID 83525 (760) 295-7208
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (Filer) CIK: 0001419051 (see all company filings)

EIN.: 451226465 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54554 | Film No.: 241221232
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)